Melanoma vaccines. Current status and future prospects.
Hersey
P
P
Department of Oncology, Royal Newcastle Hospital, New South Wales, Australia.
D000917:Antibody Formation; D000971:Antineoplastic Combined Chemotherapy Protocols; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000639:trends*; D008545:Melanoma / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy*; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D014612:Vaccines
D000949:Histocompatibility Antigens Class II; D014612:Vaccines